Litcius/Paper detail

Efficacy of Acupuncture Treatment to Prevent Cerebral Vasospasm After Subarachnoid Hemorrhage: A Double-Blind, Randomized Placebo-Controlled Trial

Dong‐Hyuk Lee, Seung‐Yeon Cho, Seung-Bo Yang, Hyoung-Min Lee, Hee Sup Shin, Seung Hwan Lee, Jun Seok Koh, Seungwon Kwon, Woo‐Sang Jung, Sang‐Kwan Moon, Jung‐Mi Park, Chang‐Nam Ko, Ho Kim, Seong-Uk Park

2020The Journal of Alternative and Complementary Medicine11 citationsDOI

Abstract

Objectives: To investigate the efficacy of acupuncture in preventing cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) and explore its underlying mechanism. Design: A randomized, double-blinded, and placebo-controlled trial. Setting/Location: Subjects were recruited from Kyung Hee University Hospital at Gangdong, Seoul, Korea Subjects: A total of 50 patients admitted with acute SAH. Interventions: The study group received acupuncture treatments (n = 25), while the control group underwent mock transcutaneous electrical nerve stimulation and sham acupuncture (n = 25) six times/week for 2 weeks. Outcome measures: The primary outcome was the incidence of delayed ischemic neurologic deficit (DIND), and secondary measurements included angiographic vasospasm, vasospasm-related infarction, modified Rankin Scale score, and plasma nitric oxide (NO) and endothelin-1 (ET-1) levels. Results: The study group treated with acupuncture showed a lower incidence of DIND (9.1%) than the control group (20.8%); however, this difference in the incidence of DIND was not statistically significant. The study group demonstrated better clinical outcomes, especially in functional recovery. Significant alterations in plasma NO and ET-1 levels after the 2-week intervention were observed only in the study group. Conclusions: Their study shows that acupuncture treatment improved functional recovery after SAH and could potentially prevent cerebral vasospasm. These effects could be attributed to the recovery of endothelial dysfunction by acupuncture through modulating the plasma NO and ET-1 levels. The study protocol has been registered on www.clinicaltrials.gov (NCT02275949).

Topics & Concepts

MedicineSubarachnoid hemorrhageVasospasmAcupunctureAnesthesiaModified Rankin ScaleCerebral vasospasmRandomized controlled trialPlaceboGlasgow Outcome ScaleInternal medicineIschemiaGlasgow Coma ScaleIschemic strokeAlternative medicinePathologyTraumatic Brain Injury and Neurovascular DisturbancesIntracranial Aneurysms: Treatment and ComplicationsAcupuncture Treatment Research Studies